Related Experiment Video
Updated: Sep 25, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Hydralazine-induced vasculitis presenting with ocular manifestations
Vivian S Hawn1, Thomas A Vo2, David Flomenbaum1
1Albert Einstein College of Medicine, 1300 Morris Park Avenue, NY, 10461, Bronx, USA.
This case report details an 88-year-old female whose hydralazine-induced vasculitis initially presented with severe ocular symptoms. Prompt treatment involving steroids and hydralazine withdrawal led to symptom resolution, emphasizing early recognition of ocular signs.
Area of Science:
- Ophthalmology
- Dermatology
- Rheumatology
Background:
- Hydralazine is a vasodilator used to treat hypertension.
- Drug-induced vasculitis can present with diverse systemic manifestations.
- Ocular involvement in drug-induced vasculitis is rare but can be severe.
Observation:
- An 88-year-old female presented with lower gastrointestinal bleeding.
- She subsequently developed bilateral conjunctival chemosis and injection.
- Progressive periorbital skin blistering indicated a systemic inflammatory process.
Findings:
- The patient was diagnosed with hydralazine-induced vasculitis.
- Ophthalmological manifestations were the initial presenting symptoms.
- Treatment included intravenous steroids and hydralazine discontinuation.
Implications:
- This case highlights the potential for ocular manifestations to be the initial sign of hydralazine-induced vasculitis.
- Early recognition of ocular symptoms is crucial for diagnosing potentially life-threatening dermatological conditions.
- This underscores the importance of a comprehensive evaluation in patients with unexplained ocular and dermatological symptoms.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Glaucoma: Overview
Endocarditis II: Clinical Features of Infective Endocarditis
Antihypertensive Drugs: Vasodilators

